Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1897 1
1911 3
1913 2
1914 1
1915 1
1916 2
1917 4
1918 3
1919 3
1920 5
1921 3
1922 10
1923 2
1924 4
1925 3
1926 11
1927 9
1928 7
1929 2
1930 3
1931 2
1932 5
1933 5
1934 9
1935 5
1936 8
1937 5
1938 8
1939 2
1940 6
1941 5
1942 3
1943 4
1944 5
1945 6
1946 29
1947 44
1948 71
1949 51
1950 87
1951 68
1952 76
1953 93
1954 68
1955 91
1956 69
1957 46
1958 74
1959 70
1960 56
1961 74
1962 87
1963 150
1964 243
1965 155
1966 87
1967 129
1968 134
1969 106
1970 149
1971 170
1972 142
1973 273
1974 406
1975 2606
1976 2747
1977 2705
1978 2861
1979 3366
1980 4929
1981 6973
1982 8054
1983 9954
1984 11763
1985 11792
1986 12170
1987 13390
1988 14063
1989 15941
1990 17472
1991 18548
1992 20046
1993 21474
1994 23513
1995 24991
1996 25149
1997 25061
1998 26267
1999 27123
2000 29269
2001 30466
2002 33804
2003 40048
2004 47106
2005 52066
2006 51424
2007 50419
2008 53968
2009 56828
2010 63513
2011 70620
2012 76804
2013 81025
2014 85489
2015 88894
2016 72790
2017 67045
2018 81505
2019 86539
2020 97510
2021 108966
2022 109403
2023 100886
2024 33559

Text availability

Article attribute

Article type

Publication date

Search Results

1,816,506 results

Results by year

Filters applied: . Clear all
Page 1
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC, Heran BS, Wright JM. Li EC, et al. Cochrane Database Syst Rev. 2014 Aug 22;2014(8):CD009096. doi: 10.1002/14651858.CD009096.pub2. Cochrane Database Syst Rev. 2014. PMID: 25148386 Free PMC article. Review.
BACKGROUND: Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood pressure > 140 mmHg or diastolic blood pressure …
BACKGROUND: Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor …
Network Meta-Analysis.
Watt J, Del Giovane C. Watt J, et al. Methods Mol Biol. 2022;2345:187-201. doi: 10.1007/978-1-0716-1566-9_12. Methods Mol Biol. 2022. PMID: 34550592
There are often multiple potential interventions to treat a disease; therefore, we need a method for simultaneously comparing and ranking all of these available interventions. In contrast to pairwise meta-analysis, which allows for the comparison of one intervention to ano …
There are often multiple potential interventions to treat a disease; therefore, we need a method for simultaneously comparing and ran …
Angiotensin-converting enzyme inhibitors.
Brown NJ, Vaughan DE. Brown NJ, et al. Circulation. 1998 Apr 14;97(14):1411-20. doi: 10.1161/01.cir.97.14.1411. Circulation. 1998. PMID: 9577953 Review.
ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive, and hypertrophic properties of angiotensin II (Ang II) and the vasodilatory and natriuretic properties of bradykinin and alter the metabolism of a number of other vasoactive …
ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive, and hypertrophic properties of angiotensin I …
Renin inhibitors.
Fisher ND, Meagher EA. Fisher ND, et al. J Clin Hypertens (Greenwich). 2011 Sep;13(9):662-6. doi: 10.1111/j.1751-7176.2011.00514.x. Epub 2011 Jul 27. J Clin Hypertens (Greenwich). 2011. PMID: 21896147 Free PMC article. Review.
It appears rational to combine aliskiren with agents that otherwise increase plasma renin activity, including thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers. ...Aliskiren is associated with …
It appears rational to combine aliskiren with agents that otherwise increase plasma renin activity, including thiazide diuretics, angiote …
Aliskiren.
Anderson DL. Anderson DL. Drugs Today (Barc). 2007 Dec;43(12):849-55. doi: 10.1358/dot.2007.43.12.977448. Drugs Today (Barc). 2007. PMID: 18174970 Review.
Food and Drug Administration and in August 2007 (as Rasilez, Enviage, Sprimeo, Tekturna and Riprazo, all from Novartis) for the treatment of essential hypertension by the European Commission. Although the indication for aliskiren is treatment of essential …
Food and Drug Administration and in August 2007 (as Rasilez, Enviage, Sprimeo, Tekturna and Riprazo, all from Novartis) for the treatment of …
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S. Husereau D, et al. Value Health. 2022 Jan;25(1):10-31. doi: 10.1016/j.jval.2021.10.008. Value Health. 2022. PMID: 35031088 Free article.
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. ...It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how t …
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. ...It …
Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
Salvador GL, Marmentini VM, Cosmo WR, Junior EL. Salvador GL, et al. Eur J Prev Cardiol. 2017 Dec;24(18):1914-1924. doi: 10.1177/2047487317728766. Epub 2017 Sep 1. Eur J Prev Cardiol. 2017. PMID: 28862020 Review.
Background There are few reviews comparing the long-term outcomes of the use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a hypertensive population because both are effective …
Background There are few reviews comparing the long-term outcomes of the use of angiotensin-converting enzyme …
Hypertension.
Oparil S, Calhoun DA. Oparil S, et al. Dis Mon. 1989 Mar;35(3):133-232. doi: 10.1016/0011-5029(89)90019-9. Dis Mon. 1989. PMID: 2565199 Review.
When used as monotherapy, most agents effectively lower BP in the majority of patients with mild or moderate essential hypertension. Thus, a single agent from one of four classes: diuretics, angiotensin-converting enzyme inhibitors …
When used as monotherapy, most agents effectively lower BP in the majority of patients with mild or moderate essential hype …
Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
Powers B, Greene L, Balfe LM. Powers B, et al. J Manag Care Pharm. 2011 Oct;17(8 Suppl):S1-14. doi: 10.18553/jmcp.2011.17.s8.1. J Manag Care Pharm. 2011. PMID: 22088101 Free PMC article. Review.
BACKGROUND: In 2007, the Agency for Healthcare Research and Quality (AHRQ) published a comparative effectiveness review (CER) on the benefits and risks of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin I …
BACKGROUND: In 2007, the Agency for Healthcare Research and Quality (AHRQ) published a comparative effectiveness review …
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE, McKinnie JJ, Greenberg SS, Giles TD. Sander GE, et al. Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):265-300. doi: 10.1053/pcad.1999.0410265. Prog Cardiovasc Dis. 1999. PMID: 10362349 Review.
Angiotensin converting enzyme (ACE) inhibition leads to increases in the vasodilatory peptides bradykinin and substance P and at least an initial reduction in angiotensin II concentrations. ...The combination ACE inhibitors and AT1 …
Angiotensin converting enzyme (ACE) inhibition leads to increases in the vasodilatory peptides bradykinin and substa …
1,816,506 results
You have reached the last available page of results. Please see the User Guide for more information.